【Bryan】評論
Tacrolimus is an immunosuppressive drug that is used mainly after allogeneic organ transplant to reduce the activity of the patient's immune system and so lower the risk of organ rejection.
【Swear】評論
Coadministration with inducers of CYP450 3A4 may decrease the plasma concentrations of tacrolimus.